JAZZ Kronos AI forecast
A 30-trading-day price forecast for Jazz Pharmaceuticals plc (JAZZ) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Jazz Pharmaceuticals plc at $237.12 on 2026-12-08, +14.7% from the last close of $206.78 on 2026-10-27. Eight out of ten sampled paths end between $231.97 and $241.59, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of JAZZ
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $213.81 | $206.97 | $219.16 |
| 2026-11-10 | $225.70 | $223.61 | $228.89 |
| 2026-11-17 | $234.19 | $228.00 | $236.69 |
| 2026-11-24 | $235.14 | $231.26 | $240.83 |
| 2026-12-01 | $235.64 | $231.81 | $243.02 |
| 2026-12-08 | $237.12 | $231.97 | $241.59 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for JAZZ?
- Kronos AI's median forecast for JAZZ is $237.12 in 30 trading days, +14.7% from the last close, with a 10–90% range of $231.97 to $241.59.
- Is the JAZZ Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC